| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 125 |
| 1 | RIVAROXABAN | 105 |
| 2 | WARFARIN | 101 |
| 3 | METHOTREXATE SODIUM | 87 |
| 4 | PREDNISOLONE | 87 |
| 5 | PREDNISOLONE ORAL | 87 |
| 6 | PREDNISOLONE ORAL SOLUTION | 87 |
| 7 | PREDNISONE | 85 |
| 8 | ASPIRIN | 82 |
| 9 | METHOTREXATE | 82 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINIDINE SULFATE TABLET | 13 | 0.0909 |
| 1 | PROCAINAMIDE HYDROCHLORIDE | 17 | 0.0705 |
| 2 | PITAVASTATIN MAGNESIUM | 1 | 0.0175 |
| 3 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0137 |
| 4 | CHLORPROMAZINE HYDROCHLORIDE | 11 | 0.0117 |
| 5 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 1 | 0.0062 |
| 6 | PENCICLOVIR | 2 | 0.0056 |
| 7 | AVATROMBOPAG MALEATE | 12 | 0.0054 |
| 8 | NINTEDANIB ESYLATE | 1 | 0.0053 |
| 9 | HYDRALAZINE HYDROCHLORIDE | 10 | 0.0038 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 246 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 147 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 146 |
| 3 | Factor Xa Inhibitor [EPC] | 139 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 86 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 83 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 75 |
| 7 | Proton Pump Inhibitor [EPC] | 71 |
| 8 | Purine Antimetabolite [EPC] | 70 |
| 9 | Benzodiazepine [EPC] | 64 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 33 | 0.0022 |
| 1 | Prostacycline [EPC] | 2 | 0.0022 |
| 2 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 37 | 0.0012 |
| 3 | Anti-coagulant [EPC] | 4 | 0.0011 |
| 4 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 5 | Human Immunoglobulin G [EPC] | 18 | 0.0009 |
| 6 | Allylamine Antifungal [EPC] | 6 | 0.0008 |
| 7 | Purine Antimetabolite [EPC] | 70 | 0.0007 |
| 8 | Blood Viscosity Reducer [EPC] | 3 | 0.0007 |
| 9 | Complement Inhibitor [EPC] | 35 | 0.0005 |